Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1,087,487 | 544,447 | 2,090,030 | 1,531,251 | 1,006,345 |
| Accounts payable and accrued liabilities | -925,534 | -471,452 | -1,804,028 | -1,335,844 | -911,227 |
| Other Working Capital | 133,982 | 65,794 | 153,625 | 85,499 | 28,335 |
| Other Operating Activity | -153,493 | -73,219 | -270,491 | -182,320 | -79,699 |
| Operating Cash Flow | $142,442 | $65,570 | $169,136 | $98,586 | $43,754 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,008 | 619 | 179,117 | 187,060 | -10,673 |
| PPE Investments | -53,172 | -22,467 | -105,444 | -77,686 | -57,510 |
| Net Acquisitions | -42,010 | N/A | -72,054 | -68,510 | -65,883 |
| Purchase Of Investment | N/A | -1,364 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -15,382 | -12,358 | -700 | -500 | -500 |
| Other Investing Activity | -15,382 | -12,358 | -700 | -500 | -500 |
| Investing Cash Flow | $-94,556 | $-35,570 | $919 | $40,364 | $-134,566 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -118 | -66 | -300,228 | -300,178 | -123 |
| Common Stock Issued | 6,473 | 3,424 | 11,237 | 9,397 | 6,580 |
| Other Financing Activity | -57 | 132 | -22,706 | -24,684 | -12,593 |
| Financing Cash Flow | $6,298 | $3,490 | $-311,697 | $-315,465 | $-6,136 |
| Exchange Rate Effect | -1,065 | -534 | 9,805 | 4,920 | 559 |
| Beginning Cash Position | 331,551 | 331,551 | 463,388 | 463,388 | 463,388 |
| End Cash Position | 384,670 | 364,507 | 331,551 | 291,793 | 366,999 |
| Net Cash Flow | $53,119 | $32,956 | $-131,837 | $-171,595 | $-96,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | 142,442 | 65,570 | 169,136 | 98,586 | 43,754 |
| Capital Expenditure | -53,510 | -22,581 | -106,658 | -78,938 | -58,598 |
| Free Cash Flow | 88,932 | 42,989 | 62,478 | 19,648 | -14,844 |